(Q34001872)

30 July 2017

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results (English)

1 reference

30 July 2017

0 references

Kenneth J Rothman

7

0 references

Til Stürmer

series ordinal

3

object named as

Til Stürmer

1 reference

30 July 2017

4

M Alan Brookhart

1 reference

PubMed ID

17909372

30 July 2017

Sebastian Schneeweiss

series ordinal

1

object named as

Sebastian Schneeweiss

1 reference

30 July 2017

8

Robert J Glynn

1 reference

30 July 2017

5

Jerry Avorn

1 reference

30 July 2017

6

Malcolm Maclure

1 reference

30 July 2017

Amanda R Patrick

2

1 reference

PubMed ID

17909372

30 July 2017

language of work or name

1 reference

1 October 2007

1 reference

30 July 2017

1 reference

30 July 2017

45

1 reference

30 July 2017

S131-42

1 reference

30 July 2017

10 Supl 2

1 reference

Insights into different results from different causal contrasts in the presence of effect-measure modification.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

A review of uses of health care utilization databases for epidemiologic research on therapeutics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Causation of bias: the episcope

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The treatment of unrelated disorders in patients with chronic medical diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Run-in periods in randomized trials: implications for the application of results in clinical practice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Estimating causal effects from large data sets using propensity scores

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Why we need observational studies to evaluate the effectiveness of health care

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Channeling bias in the interpretation of drug effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

Paradoxical relations of drug treatment with mortality in older persons.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905666

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

29 October 2018

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus

1 reference

12 December 2020

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

1 reference

12 December 2020

Selective prescribing led to overestimation of the benefits of lipid-lowering drugs

1 reference

12 December 2020

An analysis of the exclusion criteria used in observational pharmacoepidemiological studies

1 reference

12 December 2020

10.1097/MLR.0B013E318070C08E

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

17909372